Washington lawmakers are contemplating fallback healthcare legislation that risks repeating one of Albany’s most notorious policy blunders – and triggering a “death spiral” in non-group insurance markets nationwide.
The makers of the anti-addiction drug Vivitrol – whose controversial nationwide lobbying campaign was spotlighted by the New York Times last week – appear to be getting results in Albany.
The House GOP is a model of cautious deliberation next to the Assembly’s handling of the New York Health Act, which would establish a statewide single-payer plan.
With a line-item veto last week, Governor Cuomo put a last nail in the coffin of a good idea that was never given a chance by Albany: analyzing the costs and benefits of health insurance mandates before passing them into law.
To raise awareness of an expensive habit, the Empire Center will be tracking health insurance mandates as they progress through the Legislature.
The city's annual beg-a-thon is in high gear, and Mayor Sheehan is looking for help.
New York is bucking the national trend in the largest category of health insurance costs, but in exactly the wrong way.
In their latest response to the epidemic of opioid abuse, state lawmakers are indulging a habit-forming practice of their own: imposing mandates on health insurance.